Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Failure to Document Anticoagulant Side Effect Monitoring

Guthrie, Oklahoma Survey Completed on 05-15-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to document side effect monitoring for a resident prescribed an anticoagulant medication. The resident, who had diagnoses including edema, muscle weakness, and hyperlipidemia, was observed with bruising on both hands while ambulating in a wheelchair. The resident's care plan and facility policy required monitoring for adverse consequences of anticoagulant use, such as signs and symptoms of bleeding, and documentation of these findings. However, the Treatment Administration Record (TAR) from February through May did not include documentation of the observed bruising or any related side effect monitoring for anticoagulant use, nor was the bruising noted in the skin inspections. Interviews with the resident, an LPN, and the DON confirmed that the bruising was not documented in the TAR or skin inspections, despite the resident's report of easy bruising due to anticoagulant therapy and the staff's awareness of the bruising. The facility's policy specifically identified the need for staff to monitor and document adverse effects of high-risk medications like anticoagulants, but this was not followed in the case of this resident.

An unhandled error has occurred. Reload 🗙